Search research articles
Contact Us
Filters
Showing results (1-10 of 324) with videos related to
Page
of 33
Sort By:
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)
|
August 29, 2003
Update on didanosine
David A Cooper
Lancet (London, England)
|
July 29, 2008
Life and death in the cART era
David A Cooper
Journal of the International AIDS Society
|
November 14, 2014
Managing first-line failure
David A Cooper
The Medical Journal of Australia
|
February 14, 2002
HIV medicine
Sean Emery, David A Cooper
Current Opinion in HIV and AIDS
|
June 8, 2015
One year on: vale Joep Lange
David A Cooper, Giuseppe Pantaleo
Current Opinion in HIV and AIDS
|
June 8, 2013
Thirty years of HIV: what have we learned?
David A Cooper, Giuseppe Pantaleo
The New England Journal of Medicine
|
October 25, 2002
Fumagillin for intestinal microsporidiosis
Andrew Carr, David A Cooper
Current Opinion in HIV and AIDS
|
April 18, 2009
Toxicity of HIV protease inhibitors: clinical considerations
Christoph Boesecke, David A Cooper
Sexual Health
|
December 1, 2011
Optimal antiretroviral therapy for aging
Damien V Cordery, David A Cooper
Current Opinion in HIV and AIDS
|
January 6, 2010
Integrase inhibitors in salvage therapy regimens for HIV-1 infection
Kersten K Koelsch, David A Cooper
Page
of 33
Search research articles
Search
Showing results (1-10 of 324) with videos related to
Sort By:
Page
of 33
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)
|
August 29, 2003
Update on didanosine
David A Cooper
Lancet (London, England)
|
July 29, 2008
Life and death in the cART era
David A Cooper
Journal of the International AIDS Society
|
November 14, 2014
Managing first-line failure
David A Cooper
The Medical Journal of Australia
|
February 14, 2002
HIV medicine
Sean Emery, David A Cooper
Current Opinion in HIV and AIDS
|
June 8, 2015
One year on: vale Joep Lange
David A Cooper, Giuseppe Pantaleo
Current Opinion in HIV and AIDS
|
June 8, 2013
Thirty years of HIV: what have we learned?
David A Cooper, Giuseppe Pantaleo
The New England Journal of Medicine
|
October 25, 2002
Fumagillin for intestinal microsporidiosis
Andrew Carr, David A Cooper
Current Opinion in HIV and AIDS
|
April 18, 2009
Toxicity of HIV protease inhibitors: clinical considerations
Christoph Boesecke, David A Cooper
Sexual Health
|
December 1, 2011
Optimal antiretroviral therapy for aging
Damien V Cordery, David A Cooper
Current Opinion in HIV and AIDS
|
January 6, 2010
Integrase inhibitors in salvage therapy regimens for HIV-1 infection
Kersten K Koelsch, David A Cooper
Page
of 33